PODCAST

The Journal of Clinical and Aesthetic Dermatology

Matrix Medical Communications

JCAD"s audio platform provides interviews with leading experts in the dermatology field.

health & fitness medicine

All Episodes

25:33

James Del Rosso, DO, and David Cotter, MD, PhD:...

The Journal of Clinical and Aesthetic Dermatology ·

2026/04/01

Send us Fan Mail James Del Rosso, DO, and David Cotter, MD, PhD, discuss the clinical safety and efficacy of nemolizumab for patients with atopic dermatitis (AD). They highlighted a case of an 11-year-old female patient with severe AD who switched from dupilumab (Dupixent) to nemolizumab (Nemluvio). The patient achieved rapid itch reduction and resolution of conjunctivitis and facial erythema. In another case, a 22-year-old female patient with long-standing AD and joint pain switched to nemol...

en-us

18:03

James Del Rosso, DO: JCAD March 2026 Issue Highlights

The Journal of Clinical and Aesthetic Dermatology ·

2026/03/30

Send us Fan Mail James Del Rosso, DO, the Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the March 2026 issue of JCAD.

en-us

7:51

Ted Lain, MD, MBA: Long-Term Results of...

The Journal of Clinical and Aesthetic Dermatology ·

2026/03/17

Send us Fan Mail Ted Lain, MD, a board-certified dermatologist at Sanova Dermatology in Austin, Texas, shares his extensive experience with deuruxolitinib (Leqselvi) for the treatment of patients with moderate-to-severe alopecia areata. Drawing on 5 years of long-term extension data, Dr. Lain explains that patients generally maintained hair regrowth they achieved early in treatment, with no loss of effect over time. He emphasizes that this durability is crucial, as patients are often most afr...

en-us

24:22

James Del Rosso, DO: JCAD February 2026 Issue Highlights

The Journal of Clinical and Aesthetic Dermatology ·

2026/02/26

Send a text James Del Rosso, DO, the Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the February 2026 issue of JCAD.

en-us

19:29

The Use of Gene-Expression Profile Testing for...

The Journal of Clinical and Aesthetic Dermatology ·

2026/02/19

Send a text James Del Rosso, DO, and David Cotter, MD, PhD, discuss using gene expression profile testing, such as the AdvanceAD-Tx test, to provide effective treatment for patients with atopic dermatitis. AdvanceAD-Tx allows clinicians to match therapy based on patients’ immune profiles using molecular testing. Drs. Del Rosso and Cotter also review the benefits of using the test not only at baseline, but also throughout treatment in order to tailor their atopic dermatitis therapy and avoid c...

en-us

6:02

Eight-Week Outcomes With Deuruxolitinib in Alopecia...

The Journal of Clinical and Aesthetic Dermatology ·

2026/02/19

Send a text Amy McMichael, MD, a clinical professor and chair of the Department of Dermatology at Wake Forest School of Medicine, discusses deuruxolitinib for patients with alopecia areata. She highlights its 8-week efficacy compared to placebo in clinical trials. The medication provided significant improvement in hair regrowth at the 8-mg dose, with minimal adverse events. She emphasized the need to perform standard baseline and intermittent lab tests in patients, similar to other Janus kina...

en-us

8:39

Understanding Long-Term Treatment Success in a...

The Journal of Clinical and Aesthetic Dermatology ·

2026/02/17

Send a text Graham Litchman, DO, MS, a board-certified dermatologist at Vivida Dermatology in Las Vegas, Nevada, discusses a patient case involving a 54-year-old female patient with psoriasis who did not respond well to conventional treatments or systemic steroids. Dr. Lichtman introduced her to risankizumab (Skyrizi), explaining its mechanism of action, adverse events, and dosing schedule. The patient experienced significant improvement by the 3-month mark, with most plaques disappearing. Af...

en-us

22:36

James Del Rosso, DO: JCAD January 2026 Issue Highlights

The Journal of Clinical and Aesthetic Dermatology ·

2026/01/30

Send us a text James Del Rosso, DO, the Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the January 2026 issue of JCAD.

en-us

5:18

Aaron Farberg, MD: Real-World Experiences in Alopecia...

The Journal of Clinical and Aesthetic Dermatology ·

2026/01/22

Send us a text Dr. Aaron Farberg, a board-certified dermatologist and founder of Bear Dermatology in Dallas, Texas, discusses the evolving treatment landscape for alopecia areata with a focus on Janus kinase inhibitors and how he has used this type of treatment in his practice.

en-us

4:35

Arash Mostaghimi, MD, MPH, FAAD: Considerations for...

The Journal of Clinical and Aesthetic Dermatology ·

2025/12/02

Send us a text Dr. Mostaghimi discusses the speed and depth of efficacy of deuruxolitinib for providing hair regrowth in patients with severe alopecia areata.

en-us

20:01

James Del Rosso, DO: JCAD November 2025 Issue Highlights

The Journal of Clinical and Aesthetic Dermatology ·

2025/11/20

Send us a text Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the November 2025 issue of JCAD.

en-us

21:52

Extended-cut Podcast—James Del Rosso, DO, and David...

The Journal of Clinical and Aesthetic Dermatology ·

2025/11/13

Send us a text

en-us

18:53

James Del Rosso, DO: JCAD October 2025 Issue Highlights

The Journal of Clinical and Aesthetic Dermatology ·

2025/10/30

Send us a text Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the October 2025 issue of JCAD.

en-us

1:45

David G. Cotter, MD, PhD: The Ideal Patient Candidate...

The Journal of Clinical and Aesthetic Dermatology ·

2025/10/16

Send us a text Dr. Cotter discusses providing rapid hair regrowth in patients with alopecia areata.

en-us

4:42

Arash Mostaghimi, MD, MPH, FAAD: Assessing the Safety...

The Journal of Clinical and Aesthetic Dermatology ·

2025/10/16

Send us a text Dr. Mostaghimi discusses clinical research for the currently available treatments for patients with alopecia areata.

en-us

8:53

David G. Cotter, MD, PhD: Utilizing the 31-gene...

The Journal of Clinical and Aesthetic Dermatology ·

2025/10/09

Send us a text Dr. Cotter discusses results of an expert consensus panel of the 31-gene expression profile test for patients with Melanoma.

en-us

20:38

James Del Rosso, DO: JCAD September 2025 Issue...

The Journal of Clinical and Aesthetic Dermatology ·

2025/09/24

Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the September 2025 issue of JCAD.

en-us

6:33

David G. Cotter, MD, PhD: Providing Regrowth of Hair...

The Journal of Clinical and Aesthetic Dermatology ·

2025/09/22

Dr. Cotter discusses providing effective treatment for patients with alopecia areata

en-us

19:21

James Del Rosso, DO: JCAD August 2025 Issue Highlights

The Journal of Clinical and Aesthetic Dermatology ·

2025/08/26

Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the August 2025 issue of JCAD.

en-us

8:55

JCAD Dialogues and Reviews: Updates in...

The Journal of Clinical and Aesthetic Dermatology ·

2025/06/23

Dr. Del Rosso discusses advancements in photoprotection formulations, as well as recent FDA approvals that have expanded treatment options for rosacea and psoriasis.

en-us

57 results

The Journal of Clinical and Aesthetic Dermatology

All Episodes

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown